Department of the Army August 13, 2008 – Federal Register Recent Federal Regulation Documents

Intent To Grant an Exclusive License of a U.S. Government-Owned Patent
Document Number: E8-18705
Type: Notice
Date: 2008-08-13
Agency: Department of Defense, Department of the Army, Army Department
In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(I)(i), announcement is made of the intent to grant an exclusive, royalty- bearing, revocable license to U.S. Patent No. 6,451,309 entitled ``Prophylactic and Therapeutic Monoclonal Antibodies,'' issued September 17, 2002; and U.S. Patent No. 6,620,412 entitled, ``Prophylactic and Therapeutic Monoclonal Antibodies,'' issued September 16, 2003, which is a continuation of U.S. Patent No. 6,451,309, and foreign rights to BioFactura, Inc., with its principal place of business at 9700 Great Seneca Highway, Rockville, Maryland 20850.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.